ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag quotes science policy disease medicine innovation

Speaking of Science
The Scientist | Feb 1, 2016 | 2 min read
February 2016's selection of notable quotes
Notable Science Quotes
The Scientist | Jul 16, 2017 | 2 min read
The NIH budget, the nature of science, paternal age, and more
2018 in Quotes
Catherine Offord | Dec 24, 2018 | 5 min read
From the effects of political upheaval on research to claims of gene-edited babies, the year has been a tumultuous one for the scientific community.
Speaking of Science 2015
Bob Grant | Dec 30, 2015 | 3 min read
A year’s worth of noteworthy quotes
A person moving the hands of a vintage clock backwards.
Synthetic Circuits Reveal the Key to Rewinding the Cellular Clock
Charlene Lancaster, PhD | Mar 12, 2024 | 4 min read
Using a circuit-based system, scientists determined the ideal transcription factor levels to promote the successful reprogramming of fibroblasts into induced pluripotent stem cells.
Medicines for the World
Suerie Moon and Ellen â??t Hoen and Suerie Moon and Ellen â??t Hoen | Oct 1, 2012 | 5 min read
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Speaking of Science
The Scientist | Mar 1, 2016 | 2 min read
March 2016's selection of notable quotes
Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership  to develop first in class therapies in autoimmune disease and immuno-oncology
Pathios Therapeutics | Feb 7, 2019 | 2 min read
Pathios Therapeutics ("Pathios"), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery ("Sygnature"), jointly announce a strategic partnership to accelerate Pathios’ drug discovery and development programmes.

Run a Search

ADVERTISEMENT